Presentation TCT 2013 Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective? Presenter: Howard Herrmann October 28, 2013
Presentation TCT 2013 MitraClip: Utility in Functional Mitral Regurgitation Presenter: Laura Mauri October 28, 2013
Presentation TCT 2013 Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?) Presenter: Maurice Sarano October 28, 2013
Presentation TCT 2013 When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention? Presenter: Michael Davidson October 28, 2013
Presentation TCT 2013 Trying to Assess the Outcomes of Medical and Surgical Therapies for Mitral Regurgitation: Pitfalls in the Literature Presenter: Blase Carabello October 28, 2013
Presentation TCT 2013 TCT-129. Percutaneous Transfemoral Management of Severe Secondary Tricuspid Regurgitation with Edwards Sapien XT Bioprosthesis in Patients with Severe Heart Failure: First in Ma... Presenter: Michael Laule October 28, 2013
Presentation TCT 2013 TCT-128. Transcatheter Implantation of Self-Expandable Vena Cava Valves for Treatment of Tricuspid Regurgitation: First-Human-Case Description Presenter: Hans Figulla October 28, 2013
Presentation TCT 2013 Similarities and Essential Differences in the US and EU Valve Guidelines for Management of Mitral Regurgitation Presenter: Alec Vahanian October 28, 2013
Presentation TCT 2013 Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes Presenter: Dominique Himbert October 28, 2013
Presentation TCT 2013 Incidence, Predictors, and Outcomes of Paravalvular Regurgitation After TAVR Presenter: Samir Kapadia October 28, 2013
Presentation TCT 2013 Endoluminal Sciences: A New Concept for Eliminating Paravalvular Regurgitation Presenter: Raj Makkar October 28, 2013
Presentation TCT 2013 Case 1: TAVR with a Next Generation Device: Multiple Repositioning and Less Paravalvular Aortic Regurgitation? Presenter: Hans Figulla October 28, 2013
Presentation TCT 2013 Are Medical Therapies Beneficial in Functional Mitral Regurgitation? A Critical Appraisal Presenter: Robert Bonow October 28, 2013
Presentation TCT 2013 Annulus Sizing Using MSCT Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR Presenter: Jonathon Leipsic October 28, 2013
News Conference News TCT 2013 Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients October 28, 2013
Presentation TCT 2013 Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator Presenter: Tim Lapp October 27, 2013
Presentation TCT 2013 The MitraClip Procedure For Functional Mitral Regurgitation Results In A Significant Change In Procedural Hemodynamics. Presenter: Wen Loong Yeow, Mamoo Nakamura, Takashi Matsumoto, Hasan Jilaihawi, Asma Hussaini, Moody Makar, Swaminatha V. Gurudevan, Robert Siegel, Saibal Kar January 31, 2013
Presentation TCT 2013 Successful Transfemoral Implantation of a Medtronic CoreValve in Patients with Severe Aortic Regurgitation: a Single Centre Experience Presenter: Marco Luciano Rossi, Roberto Bocchi, Paolo Pagnotta, Gabriele Gasparini, Dennis Zavalloni, Patrizia Presbitero January 31, 2013